DL
Daniel Lynch
Angel InvestorQuietExecutive Venture Partner at GV
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Daniel Lynch.
Investment Thesis & Strategy
Daniel Lynch, as an angel investor, likely invests in biotech and pharmaceutical companies across various stages, leveraging his experience as an Executive Venture Partner at GV. He likely seeks innovative companies with strong potential for growth and market impact.
Investment Activity
Deals per year over the last 3 years
1
20101
20111
2012Portfolio Companies
Selected investments from their portfolio of 4 companies
I
Inc.
Other · Seed, 0
B
Blueprint Medicines
Biotech · Series A, 2012
L
Lime&Tonic
Food & Beverage · Seed, 2011
S
Sesen Bio
Biotech · Series A, 2010
Frequently Asked Questions
Daniel Lynch focuses on Seed, Series B, Series A stage investments.